FDA Inspection 885331 — Joslin Diabetes Center Committee On Human Studies

Joslin Diabetes Center Committee On Human Studies — FEI 1283624

The FDA completed an inspection of Joslin Diabetes Center Committee On Human Studies on Jun 27, 2014 in Boston, MA. The inspection was classified VAI (Voluntary Action Indicated — objectionable conditions or practices were found, but the agency is not prepared to take or recommend any administrative or regulatory action). 1 citation was issued during this inspection. Product area: Drugs.

Inspection details

Classification
Voluntary Action Indicated (VAI)
End Date
Jun 27, 2014
Fiscal Year
2014
Product Type
Drugs
Project Area
Bioresearch Monitoring
Location
Boston, MA (United States)

Additional details

IRB

Citations

IDCFRDescription
729721 CFR 56.109(b)Information given to subjects

Sources: openFDA, FDA Data Dashboard, FDA.gov. Report a data issue: hello@regdatalab.com.